Waddell & Associates’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
RP
ACM
CAM
AIM
GIA
PFSRSONJ
Waddell & Associates's MEDP Position: Q2 2026 in Review
Waddell & Associates reduced its Medpace (MEDP) stake by 6.5% in Q2 2026, selling an estimated $43.8K and leaving 1,356 shares worth $718K. The position accounts for 0.04% of the portfolio, ranked #185.
Waddell & Associates first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $817K in Q4 2025. 121 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Waddell & Associates held 1,356 shares of Medpace worth $718K as of Q2 2026.
- Waddell & Associates sold 95 Medpace shares in Q2 2026, an estimated $43.8K.
- Medpace made up 0.04% of Waddell & Associates's portfolio in Q2 2026, its #185 holding.
- Waddell & Associates first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
- Waddell & Associates's Medpace position peaked at $817K in Q4 2025.
- 121 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.